Patients with Glioblastoma (GBM), a highly aggressive malignant brain tumor, have an extremely poor prognosis due to a lack of viable treatment choices. Since being named the “breakthrough of the year ...

Immuno-PET imaging is an advanced molecular diagnostic technique that merges the high sensitivity of positron emission tomography with the exquisite target specificity of monoclonal antibodies. By ...

A novel therapeutic approach that combines human epidermal growth receptor factor 2 (HER2)-targeted therapies with the cholesterol-lowering drug lovastatin can reduce the number of cancer treatments ...

SUZHOU, China, March 3, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, ...

Monoclonal Antibody-Based Therapies: A New Dawn in the Treatment of Acute Lymphoblastic Leukemia Identification of cancer cell–surface biomarkers and advances in antibody engineering have led to a ...

IL12/23p40 immuno-PET/CT imaging of healthy and DSS-treated mice. Representative maximum-intensity projection images of healthy (left) and DSS-treated (right) mice acquired at 24 hours (day 6) and 48 ...

A new radiotheranostic system has the ability to detect and treat ovarian cancer noninvasively, according to new research published in the April issue of The Journal of Nuclear Medicine. Combining the ...

A positron emission tomography (PET) scan is an imaging technique that uses small amounts of radioactive substances. Doctors may use PET scans in chemotherapy treatments for cancer. PET scans help ...

Positron emission tomography (PET) scans can detect cancer earlier than other imaging tests. But some types of cancer are harder to detect on a PET scan. In particular, they may miss cancers that ...

Representative PET images of 89 ZrDFO-trastuzumab displaying %ID/g acquired 48 hours after radiolabeled trastuzumab injection on day 39 for T-DM1 single-treatment regime, T-DM1/statin single-treatment ...